Login / Signup

Beginning at the End? Rethinking the Timing of Enrollment Into Early Phase Clinical Trials.

Aditya MahadevanArmon AziziFarshid Dayyani
Published in: JCO oncology practice (2024)
Keyphrases
  • clinical trial
  • health insurance
  • phase ii
  • open label
  • affordable care act
  • phase iii
  • double blind